Category: Patents
-
Warner Bros. Discovery “pulls a Samsung” against Nokia with U.S. FRAND/antitrust claims after similar ones in other venues; also argues exhaustion by Apple, Amazon licenses
in the midst of a major merger battle, Warner Bros. Discovery is pursuing FRAND matters in at least three different venues now.
-
Nokia strikes Hisense license deal as TV maker prefers global patent peace over London dead end; Acer, ASUS lose important co-defendant
Unlike Hisense, Acer and ASUS make computers that are also used for recording video. Encoding claims, however, are outside the ITU FRAND scope.
-
BREAKING: InterDigital, Xiaomi renew patent license agreement without litigation; five-year term; cellular, WiFi, HEVC patents included
InterDigital has signed a new major license agreement with a party that is undisclosed, but whose name can be deduced from previously available information.
-
Tesla should learn from Amazon-InterDigital, take an Avanci 5G license: even if its long-shot UKSC appeal succeeded, it wouldn’t help
For cross-jurisdictional reasons, Tesla should give up on its UK case against Avanci and InterDigital, in which it lost the first two rounds.
-
UPC President denies Amazon motion to stay enforcement of InterDigital’s anti-interim-license injunction; Amazon may already be in breach
This does not mean that Amazon’s appeal will necessarily fail, but Amazon could now face contempt proceedings any day.
-
CJEU publishes European Parliament’s suit against European Commission’s decision to withdraw SEP Regulation
The Commission “prematurely” brought the legislative procedure to an end without legitimate grounds supported by cogent evidence and arguments for doing so, the EP has alleged.
-
Make SEPs Great Again: after President’s memo on 6G, USPTO forms SEP Working Group “to renew American leadership in technology standards”
With President Trump’s 6G memo before and the USPTO’s SEP Working Group announcement after Christmas, standards and the related patents get unprecedented political attention.
-
Novo Nordisk suffers another loss in efforts to extend key Ozempic patent in Brazil
Brazil’s Superior Tribunal de Justiça has issued its first-ever decision on patent term adjustment, ruling that Novo Nordisk’s request to extend its Ozempic-related patent is unconstitutional because a drugmaker’s rights to a patent term cannot override society’s rights to affordable medicine.
-
BREAKING: Within hours of Brazilian injunction, HEVC Advance lists Hisense as licensee
The Brazilian court gave Hisense only 48 hours to comply. and a preliminary injunction based on a report by a court-appointed expert has teeth.

